Maravai LifeSciences
Critical products and CDMO services enabling vaccine, therapeutic, and diagnostic development from discovery to commercialization.
Listed on cdmo.directory
Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Manufacturing (M)
Regulatory clearances
Services
Indications
About this organization
Maravai LifeSciences is a life sciences company providing critical products and services across the biopharmaceutical development lifecycle. The company operates through four primary brands:
TriLink BioTechnologies — Global leader in RNA synthesis and scale-up, including mRNA production with proprietary CleanCap® mRNA capping technology. Offers CDMO services ranging from research to GMP grades.
Glen Research — Specialty reagents for DNA and RNA oligonucleotide synthesis across a broad range of applications.
Cygnus Technologies — Bioprocess impurity detection, process-related impurity analytics, and viral clearance assays for therapeutic antibodies, proteins, gene therapies, vaccines, and plasma derivatives.
Alphazyme — Manufacturer of molecular biology enzymes for molecular diagnostics and nucleic acid therapy applications.
The company supports customers from discovery and process development through clinical manufacturing, with expertise in nucleic acids, custom enzymes, and antibody-based detection products. Portfolio companies are ISO-9001:2015 certified.
Certifications
Submit a verified review for this organization.
Markdown mirror: /companies/maravai.md